Keyphrases
Basal Conditions
50%
Cerebral Microdialysis
16%
Cheese Effect
16%
Clorgyline
33%
Deprenyl
33%
DOPAC
50%
Dopamine
100%
Dopamine Metabolism
100%
Dopamine Metabolites
33%
Glial Metabolism
16%
L-DOPA
100%
L-dopamine
100%
MAO Inhibitors
33%
MAO-B Inhibitors
16%
Metabolite Concentrations
16%
Microdialysis
16%
Monoamine Oxidase A (MAO-A)
100%
Monoamine Oxidase B (MAO-B)
100%
Non-selective
33%
Pargyline
16%
Parkinson's Disease
16%
Selective Inhibitor
16%
Striatal
100%
Neuroscience
Clorgiline
33%
In Vivo
100%
L-DOPA
100%
Metabolic Pathway
100%
Microdialysis
16%
Monoamine Oxidase Inhibitor
33%
Pargyline
16%
Treatment of Parkinson's Disease
16%
Pharmacology, Toxicology and Pharmaceutical Science
3,4 Dihydroxyphenylacetic Acid
50%
Clorgiline
33%
DOPA
100%
Microdialysis
16%
Monoamine Oxidase A Inhibitor
16%
Monoamine Oxidase B Inhibitor
16%
Monoamine Oxidase Inhibitor
33%
N (2 Aminoethyl) 5 (3 Fluorophenyl) 4 Thiazolecarboxamide
33%
Pargyline
16%
Parkinson's Disease
16%
Selegiline
33%